Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 3/20 | 0.40 |
| ▸ | FNTB | P49356 | 3/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.36 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.36 |
| ▸ | NOD1 | Q9Y239 | 4/20 | 0.35 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | GLP1R | P43220 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7977308 | 0.78 | NOD1 (0.41) | FNTAFNTBHDAC2PGGT1BNOD1 | |
| SCHEMBL7974823 | 0.72 | ALDH1A1 (0.47) | — | |
| Hydrochloric Acid SCHEMBL7979896 | 0.69 | FOLH1 (0.39) | FOLH1 | |
| SCHEMBL7973799 | 0.67 | ALDH1A1 (0.37) | FOLH1 | |
| SCHEMBL7977282 | 0.64 | TDP1 (0.40) | — | |
| SCHEMBL7975044 | 0.63 | NOD1 (0.43) | FNTAFNTBPGGT1BNOD1FOLH1 | |
| SCHEMBL11092611 | 0.62 | NOD1 (0.68) | FNTAFNTBHDAC2NOD1SLC6A5 | |
| SCHEMBL14554164 | 0.62 | FNTA (0.60) | FNTAFNTBPGGT1BNOD1MAPK1 | |
| SCHEMBL7974957 | 0.62 | ALDH1A1 (0.36) | — | |
| SCHEMBL753572 | 0.62 | FNTA (0.60) | FNTAFNTBPGGT1BNOD1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2001005748-A1 | OLIGOMERIC AMINO ACID DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS | MONSANTO COMPANY (US) | 2001-01-25 | — | — | WO | disclosed |